A small umbrella which may be removably attached to a beverage container in order to shade the beverage container from the direct rays of the sun.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 6310185 | Recombinant human anti-Lewis Y antibodies The invention provides for the production of several humanized murine antibodies specific for the antigen Lewis Y, which is recognized by murine atibodies specific for the Lewis Y antigen. The Lewis Y antigen is expressed in normal tissues but the level o... | 10/30/2001 |
| 6284476 | Method of identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen/tyrosinase derived peptides, and methods for treating said individuals The invention relates to the identification of complexes of human leukocyte antigen molecules and tyrosinase derived peptides on the surfaces of abnormal cells. The diagnostic ramifications of this observation are the subject of the invention.... | 09/04/2001 |
| 6253142 | Traction control system for motor vehicles The coefficient of friction μs between the wheels of the vehicle and the road surface is identified as a function of the slip, and the maximum drive torque MAmax which can be transmitted is determined as a function of this slip-dependent coeff... | 06/26/2001 |
| 6235525 | Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-3 and uses thereof The invention relates to nucleic acid molecules which code for the tumor rejection antigen precursor MAGE-3. Also disclosed are vectors, cell lines, and so forth, which utilize the nucleic acid molecule, and optionally, molecules coding for human leukocyt... | 05/22/2001 |
| 6150437 | Flow improving agents for binder suspensions containing cement Flow improving agents for binder suspensions containing cement are described, which consist of: a) Graft polymers which have been prepared by radical grafting of a polyalkylene oxide of the general formula (I) with an ethylenically unsaturated mono- or di... | 11/21/2000 |
| 6140464 | Nonapeptides that bind a HLA-A2.1 molecule The invention described methods for identifying a molecule of interest, as well as nucleic acid molecules which encode it, and binding partners for it. A cDNA library from a cell expressing the target is prepared, and expressed in host cells. Lysates of t... | 10/31/2000 |
| 6056451 | Photographic film processing apparatus A photographic film processing apparatus for processing long developed film (10b) formed by joining photographic films with a splicing material (13). The apparatus includes a first transport device (40a) for transporting the long developed film. A region ... | 05/02/2000 |
| 6057115 | Process for producing GM2 specific antibodies The invention relates to the production of ganglioside specific antibodies. These antibodies are produced following immunization with lipopolysaccharide antigen of Campylobacter jejuni. The antibodies bind to monosialogangliosides, including GM2 and GM1.... | 05/02/2000 |
| 6025191 | Isolated nucleic acid molecules which encode a melanoma specific antigen and uses thereof The invention involves the isolation of a nucleic acid molecule which encodes a melanoma associated antigen. Cell lines and expression vectors which include this and related sequences, as well as uses of these molecules, are described.... | 02/15/2000 |
| 5965424 | Methods for making neisseria or hemophilus IgA protease and DNA encoding the proteases The present invention concerns a process for the isolation of recombinant IgA protease from inclusion bodies. In addition a recombinant DNA is claimed which codes for an IgA protease whose C-terminal helper sequence and preferably also its N-terminal sign... | 10/12/1999 |
| 5932694 | Nucleic acid molecule encoding a bifunctional protein, the protein so encoded and uses thereof The invention involves the identification of an isolated nucleic acid molecule which encodes a tumor rejection antigen. Various uses of this nucleic acid molecule and the protein it encodes are discussed.... | 08/03/1999 |
| 5925729 | Tumor rejection antigen precursors, tumor rejection antigens and uses thereof The invention relates to an isolated DNA sequence which codes for an antigen expressed by tumor cells which is recognized by cytotoxic T cells, leading to lysis of the tumor which expresses it. Also described are cells transfected by the DNA sequence, and... | 07/20/1999 |
| 5918952 | Wheel slippage control system A processing circuit has a computing cycle divided into several subcycles of uniform duration. The time base values of the last three nulls of a square wave signal produced from the sinusoidal signal of a wheel speed sensor are stored in a register with t... | 07/06/1999 |
| 5877017 | Isolated nucleic acid molecule encoding peptides which form complexes with MHC molecule HLA-Cw*1601 and uses thereof A family of tumor rejection antigen precursors, and the nucleic acid molecules which code for them, are disclosed. These tumor rejection antigen precursors are referred to as BAGE tumor rejection antigen precursors, and the nucleic acid molecules which co... | 03/02/1999 |
| 5867460 | Apparatus for laser beam exposure of a substrate disc In an apparatus for the laser beam exposure of a substrate disc (5), linked block tables (19, 29) are provided, which have each a piezotranslator (24, 31). This makes it possible to perform a fine correction of the movements very rapidly and very precisel... | 02/02/1999 |
| 5864015 | Hodgkin's disease associated molecules The invention describes identification and isolation of molecules associated specifically with Hodgkin's Disease. Uses of the molecules are described as well.... | 01/26/1999 |
| 5859314 | Mice with targeted tyrosine kinase, lyn, disruption A non-human animal carrying a disruption of a gene encoding a lyn protein tyrosine kinase provides a convenient system for the study of diseases associated with or caused by lyn deficiency, and for the testing of therapeutic agents for the treatment or pr... | 01/12/1999 |
| 5854007 | Process for producing GM1 specific antibodies The invention relates to the production of ganglioside specific antibodies. These antibodies are produced following immunization with lipopolysaccharide antigen of Campylobacter jejuni. The antibodies bind to monosialogangliosides, including GM2 and GM1.... | 12/29/1998 |
| 5854203 | Tumor rejection antigen precursor processed to at least one tumor rejection antigen presented by HLA-A2 The invention relates to nucleic acid molecules coding for a tumor rejection antigen precursor. Specifically, the tumor rejection antigen precursor, or "TRAP", is processed into at least one tumor rejection antigen, which is presented by HLA-A2 molecules.... | 12/29/1998 |
| 5853668 | Apparatus allowing sequential chemical reactions A first reactant is immobilized i.e. in a porous matrix (50), adjacent a sample electrode (46) within a reaction chamber. Energizing of the electrode (46) electrophoretically attracts a mobile second reactant and/or electrolytically induces appropriate re... | 12/29/1998 |
| 5851526 | Methods of treating colon cancer utilizing tumor-specific antibodies This invention relates to methods of reducing the effects of colon cancer tumors. Various agents are conjugated to monoclonal antibodies which are specific for colon cancer cells. The conjugates are administered to patients having colon cancer such that t... | 12/22/1998 |
| 5851840 | Biotinsilane compounds and a binding matrix containing these compounds The invention concerns a binding matrix containing a carrier material with an oxidic surface and a solid phase reactant covalently bound thereto via anchor groups which is capable of binding to at least one free reaction partner, which is characterized in... | 12/22/1998 |
| 5852184 | Protein tyrosine kinase The present invention is directed to a novel protein tyrosine kinase comprising a polypeptide having multiple protein kinase catalytic domains and, more particularly, two kinase catalytic domains and to genetic sequences encoding same. Two such kinases ar... | 12/22/1998 |
| 5849904 | Isolated nucleic acid molecules which hybridize to polysialyl transferases Isolated nucleic acid molecules encoding polysialyl transferases, and the polysialyl transferases themselves are disclosed. SEQ ID NOS: 1, 2, 7 and 8 present examples of these. The nucleic acid molecules and the proteins can be used diagnostically or ther... | 12/15/1998 |
| 5849087 | Vacuum treatment system for applying thin layers to substrates such as headlights reflectors In a vacuum treatment system for applying thin layers to substrates (2, 2', . . . ) such as headlight reflectors, with several treatment (8, 9, 10) and/or inward and outward transfer lock stations (20) supported on a stationary vacuum chamber wall (16, 16... | 12/15/1998 |
| 5846826 | Isolated cytolytic T cell line specific to complexes of HLA-B44 molecules and specific nonapeptides The invention involves cytolytic T cell lines which are specific for complexes of HLA-B44 molecules and nonamers which bind to these.... | 12/08/1998 |
| 5843859 | Reaction-formed moulded ceramic body containing mullite, its production and its use A reaction-formed moulded ceramic body containing mullite is described which is obtainable by heat treating a body moulded from a finely dispersed powder mixture of aluminium, Al2 O3 and a material containing Si in an atmosphere cont... | 12/01/1998 |
| 5843687 | Isolated, tyrosinase derived peptides and uses thereof The invention relates to the identification of complexes of human leukocyte antigen molecules and tyrosinase derived peptides on the surfaces of abnormal cells. The therapeutic and diagnostic ramifications of this observation are the subject of the invent... | 12/01/1998 |
| 5844124 | Method and apparatus for measuring odorant concentration and oderant adding system A method, an apparatus, and an integrated system using the apparatus for measuring a concentration of odorant in odorized gas which is produced by adding the odorant to un-odorized gas comprised mainly of hydrocarbon gas. In a detection absorbance measuri... | 12/01/1998 |
| 5843688 | Isolated tyrosinase derived peptides and uses thereof The invention relates to the identification of complexes of human leukocyte antigen molecules and tyrosinase derived peptides on the surfaces of abnormal cells. The therapeutic and diagnostic ramifications of this observation are the subject of the invent... | 12/01/1998 |
| 5840568 | Hodgkin's disease associated molecules and uses thereof The invention describes identification and isolation of molecules associated specifically with Hodgkin's Disease. Uses of the molecules are described as well.... | 11/24/1998 |
| 5838457 | Index printing apparatus including exposure control means A photographic printing apparatus capable of printing, as an index print, an inlaid composite image having images of a plurality of frames of a film. An exposure device 10 of this printing apparatus includes an exposure controller 104 for controlling this... | 11/17/1998 |
| 5830753 | Isolated nucleic acid molecules coding for tumor rejection antigen precursor dage and uses thereof. A new family of tumor rejection antigen precursors, and the nucleic acid molecules which code for them, are disclosed. These tumor rejection antigen precursors are referred to as DAGE tumor rejection antigen precursors, and the nucleic acid molecules whic... | 11/03/1998 |
| 5830816 | Sintered molding Zirconium dioxide containing 2 to 40 vol. % of stabilizing oxides is embedded in the matrix material of a sintered molding consisting of an aluminum oxide/chromium oxide mixed crystal. The quantity of stabilizing oxides added is chosen so that the zirconi... | 11/03/1998 |
| 5831309 | Semiconductor element for an electronic or opto-electronic semiconductor component Semifinished products designed as composite bodies for electronic or opto-electronic semiconductor components are known. The composite bodies are made of a disk-shaped, transparent quartz glass substrate and a wafer made of a semiconductor material. The d... | 11/03/1998 |
| 5830454 | Method for treating cell mediated autoimmune disorders using interleukin-9 A method for the treatment of cell mediated autoimmune disease is disclosed. The method involves administering interleukin-9 in an effective amount to the subject. Among the conditions treatable are thyroiditis and autoimmune diabetes.... | 11/03/1998 |
| 5832402 | Modular vehicle dynamics control system The movement of a vehicle is controlled by actuating actuators which apply a braking force to the wheels. For this purpose, the rotational speeds of the wheels, the steering angle and at least one of the lateral acceleration and the yawing movement of the... | 11/03/1998 |
| 5827566 | Process and device for wetting particles with a fluid Disclosed are a process and a device for wetting pneumatically transported particles with a fluid where the fluid is sprayed by means of nozzles into a transport line through which the particles are flowing. The nozzles are installed in an area of the tra... | 10/27/1998 |
| 5827073 | Photoreactive peptide derivatives The invention relates to methods for making synthetic, photoreactive peptides and their use. A photoreactively labelled amino acid is incorporated into the peptide. The resulting peptide, when compared to the non-labelled form, is not impaired with respec... | 10/27/1998 |
| 5824551 | Method for modulating cell apoptosis The invention is based upon the newly recognized ability of ଲ chemokines to inhibit cell apoptosis. In particular, apoptosis of T cells is described. The known ଲ chemokines I-309 and TCA-3 are examples of the ଲ chemokines which inhibit a... | 10/20/1998 |